HEADER REPLICATION 09-OCT-14 4RJF TITLE CRYSTAL STRUCTURE OF THE HUMAN SLIDING CLAMP AT 2.0 ANGSTROM TITLE 2 RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROLIFERATING CELL NUCLEAR ANTIGEN; COMPND 3 CHAIN: A, C, E; COMPND 4 SYNONYM: PCNA, CYCLIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CYCLIN-DEPENDENT KINASE INHIBITOR 1; COMPND 8 CHAIN: B, D, F; COMPND 9 FRAGMENT: 22 C TERMINAL RESIDUES (139 - 160); COMPND 10 SYNONYM: CDK-INTERACTING PROTEIN 1, MELANOMA DIFFERENTIATION- COMPND 11 ASSOCIATED PROTEIN 6, MDA-6, P21; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PCNA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMCSG19; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 OTHER_DETAILS: P21 PEPTIDE CHEMICALLY SYNTHESIZED KEYWDS SLIDING CLAMP, PROCESSIVITY FACTOR, P21, DNA POLYMERASE, NUCLEUS, KEYWDS 2 REPLICATION EXPDTA X-RAY DIFFRACTION AUTHOR A.J.KROKER,J.B.BRUNING REVDAT 2 20-SEP-23 4RJF 1 SEQADV REVDAT 1 26-AUG-15 4RJF 0 JRNL AUTH A.J.KROKER,J.B.BRUNING JRNL TITL P21 EXPLOITS RESIDUE TYR151 AS A TETHER FOR HIGH-AFFINITY JRNL TITL 2 PCNA BINDING. JRNL REF BIOCHEMISTRY V. 54 3483 2015 JRNL REFN ISSN 0006-2960 JRNL PMID 25972089 JRNL DOI 10.1021/ACS.BIOCHEM.5B00241 REMARK 2 REMARK 2 RESOLUTION. 2.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : TWIN_LSQ_F REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.27 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.980 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 63385 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.155 REMARK 3 R VALUE (WORKING SET) : 0.148 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.120 REMARK 3 FREE R VALUE TEST SET COUNT : 1976 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.8886 - 4.8163 0.97 4383 149 0.1388 0.1496 REMARK 3 2 4.8163 - 3.8318 0.97 4371 136 0.1206 0.1714 REMARK 3 3 3.8318 - 3.3501 0.97 4398 139 0.1371 0.1862 REMARK 3 4 3.3501 - 3.0449 0.97 4342 143 0.1438 0.1627 REMARK 3 5 3.0449 - 2.8273 0.97 4386 140 0.1508 0.2164 REMARK 3 6 2.8273 - 2.6611 0.97 4384 139 0.1612 0.1800 REMARK 3 7 2.6611 - 2.5281 0.97 4388 140 0.1647 0.1736 REMARK 3 8 2.5281 - 2.4182 0.97 4348 139 0.1693 0.2612 REMARK 3 9 2.4182 - 2.3253 0.97 4385 138 0.1782 0.2038 REMARK 3 10 2.3253 - 2.2451 0.97 4410 146 0.1801 0.2725 REMARK 3 11 2.2451 - 2.1750 0.97 4303 140 0.1856 0.2176 REMARK 3 12 2.1750 - 2.1129 0.97 4424 141 0.1951 0.2532 REMARK 3 13 2.1129 - 2.0574 0.97 4367 140 0.2003 0.2536 REMARK 3 14 2.0574 - 2.0072 0.97 4390 146 0.2149 0.3063 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.770 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: 0.4900 REMARK 3 OPERATOR: -H,-K,L REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 6358 REMARK 3 ANGLE : 0.631 8566 REMARK 3 CHIRALITY : 0.025 1007 REMARK 3 PLANARITY : 0.003 1093 REMARK 3 DIHEDRAL : 12.848 2375 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4RJF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-OCT-14. REMARK 100 THE DEPOSITION ID IS D_1000087420. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : RIGAKU VARIMAX HF MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.1.27 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 63388 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.007 REMARK 200 RESOLUTION RANGE LOW (A) : 41.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : 0.05500 REMARK 200 FOR THE DATA SET : 25.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.01 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.44900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.1 REMARK 200 STARTING MODEL: 1AXC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.08M STRONTIUM CHLORIDE HEXAHYDRATE, REMARK 280 0.02M MAGNESIUM CHLORIDE HEXAHYDRATE, 0.04M SODIUM CACODYLATE REMARK 280 TRIHYDRATE (PH7.0), 20% V/V (+/-)-2-METHYL-2,4-PENTANEDIOL AND REMARK 280 0.012M SPERMINE TETRAHYDROCHLORIDE, FINAL [PCNA] = 11.6MG/ML = REMARK 280 0.40MM, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 247.63130 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -214.45500 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 123.81565 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 142.97000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 247.63130 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -142.97000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 247.63130 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 71.48500 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 123.81565 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -71.48500 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 123.81565 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 256 REMARK 465 ASP A 257 REMARK 465 GLU A 258 REMARK 465 GLU A 259 REMARK 465 GLY A 260 REMARK 465 SER A 261 REMARK 465 GLY B 139 REMARK 465 VAL C 188 REMARK 465 ASP C 189 REMARK 465 GLU C 256 REMARK 465 ASP C 257 REMARK 465 GLU C 258 REMARK 465 GLU C 259 REMARK 465 GLY C 260 REMARK 465 SER C 261 REMARK 465 GLY D 139 REMARK 465 ARG D 140 REMARK 465 ASN E 107 REMARK 465 GLN E 108 REMARK 465 ASN E 187 REMARK 465 VAL E 188 REMARK 465 ASP E 189 REMARK 465 LYS E 190 REMARK 465 GLU E 256 REMARK 465 ASP E 257 REMARK 465 GLU E 258 REMARK 465 GLU E 259 REMARK 465 GLY E 260 REMARK 465 SER E 261 REMARK 465 GLY F 139 REMARK 465 ARG F 140 REMARK 465 LYS F 141 REMARK 465 ARG F 142 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 95 CG OD1 ND2 REMARK 470 ASP A 97 CG OD1 OD2 REMARK 470 ASP A 165 CG OD1 OD2 REMARK 470 ASN A 187 CG OD1 ND2 REMARK 470 VAL A 188 CG1 CG2 REMARK 470 ASP A 189 CG OD1 OD2 REMARK 470 GLU A 198 CG CD OE1 OE2 REMARK 470 ILE A 255 CG1 CG2 CD1 REMARK 470 ARG B 140 N CA CB CG CD NE CZ REMARK 470 ARG B 140 NH1 NH2 REMARK 470 LYS B 141 CG CD CE NZ REMARK 470 GLU C 17 CB CG CD OE1 OE2 REMARK 470 LEU C 22 CB CG CD1 CD2 REMARK 470 TRP C 28 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP C 28 CZ3 CH2 REMARK 470 SER C 39 CB OG REMARK 470 ASN C 95 CG OD1 ND2 REMARK 470 ASP C 97 CB CG OD1 OD2 REMARK 470 SER C 186 N REMARK 470 GLU C 191 CG CD OE1 OE2 REMARK 470 LYS D 141 N CA O CB CG CD CE REMARK 470 LYS D 141 NZ REMARK 470 HIS D 152 CG ND1 CD2 CE1 NE2 REMARK 470 GLU E 109 CG CD OE1 OE2 REMARK 470 ASP E 113 CG OD1 OD2 REMARK 470 SER E 152 OG REMARK 470 LYS E 164 CG CD CE NZ REMARK 470 LEU E 182 CG CD1 CD2 REMARK 470 ILE E 255 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 44 16.37 59.96 REMARK 500 GLU A 93 -156.64 -101.08 REMARK 500 ASN A 95 30.04 -95.27 REMARK 500 ASP A 97 30.21 -98.44 REMARK 500 PRO A 106 45.59 -79.09 REMARK 500 GLU A 109 -13.23 -170.55 REMARK 500 ALA A 163 -154.22 -105.55 REMARK 500 ASN A 187 44.68 -72.97 REMARK 500 LYS A 190 -166.64 -163.56 REMARK 500 GLU A 191 -45.87 -160.72 REMARK 500 MET A 244 -73.47 -134.98 REMARK 500 ARG B 142 -45.40 -147.82 REMARK 500 SER C 39 145.73 -173.97 REMARK 500 GLN C 108 9.17 51.87 REMARK 500 GLU C 109 40.04 -98.93 REMARK 500 LYS C 110 118.13 -163.85 REMARK 500 MET C 244 -42.46 -141.71 REMARK 500 ARG D 142 28.28 -147.23 REMARK 500 LYS E 20 0.19 -65.95 REMARK 500 ALA E 163 -168.07 -127.17 REMARK 500 PRO E 234 144.13 -38.81 REMARK 500 ALA E 242 105.44 -39.70 REMARK 500 MET E 244 -42.60 -137.42 REMARK 500 REMARK 500 REMARK: NULL DBREF 4RJF A 1 261 UNP P12004 PCNA_HUMAN 1 261 DBREF 4RJF B 139 160 UNP P38936 CDN1A_HUMAN 139 160 DBREF 4RJF C 1 261 UNP P12004 PCNA_HUMAN 1 261 DBREF 4RJF D 139 160 UNP P38936 CDN1A_HUMAN 139 160 DBREF 4RJF E 1 261 UNP P12004 PCNA_HUMAN 1 261 DBREF 4RJF F 139 160 UNP P38936 CDN1A_HUMAN 139 160 SEQADV 4RJF PHE B 151 UNP P38936 TYR 151 ENGINEERED MUTATION SEQADV 4RJF PHE D 151 UNP P38936 TYR 151 ENGINEERED MUTATION SEQADV 4RJF PHE F 151 UNP P38936 TYR 151 ENGINEERED MUTATION SEQRES 1 A 261 MET PHE GLU ALA ARG LEU VAL GLN GLY SER ILE LEU LYS SEQRES 2 A 261 LYS VAL LEU GLU ALA LEU LYS ASP LEU ILE ASN GLU ALA SEQRES 3 A 261 CYS TRP ASP ILE SER SER SER GLY VAL ASN LEU GLN SER SEQRES 4 A 261 MET ASP SER SER HIS VAL SER LEU VAL GLN LEU THR LEU SEQRES 5 A 261 ARG SER GLU GLY PHE ASP THR TYR ARG CYS ASP ARG ASN SEQRES 6 A 261 LEU ALA MET GLY VAL ASN LEU THR SER MET SER LYS ILE SEQRES 7 A 261 LEU LYS CYS ALA GLY ASN GLU ASP ILE ILE THR LEU ARG SEQRES 8 A 261 ALA GLU ASP ASN ALA ASP THR LEU ALA LEU VAL PHE GLU SEQRES 9 A 261 ALA PRO ASN GLN GLU LYS VAL SER ASP TYR GLU MET LYS SEQRES 10 A 261 LEU MET ASP LEU ASP VAL GLU GLN LEU GLY ILE PRO GLU SEQRES 11 A 261 GLN GLU TYR SER CYS VAL VAL LYS MET PRO SER GLY GLU SEQRES 12 A 261 PHE ALA ARG ILE CYS ARG ASP LEU SER HIS ILE GLY ASP SEQRES 13 A 261 ALA VAL VAL ILE SER CYS ALA LYS ASP GLY VAL LYS PHE SEQRES 14 A 261 SER ALA SER GLY GLU LEU GLY ASN GLY ASN ILE LYS LEU SEQRES 15 A 261 SER GLN THR SER ASN VAL ASP LYS GLU GLU GLU ALA VAL SEQRES 16 A 261 THR ILE GLU MET ASN GLU PRO VAL GLN LEU THR PHE ALA SEQRES 17 A 261 LEU ARG TYR LEU ASN PHE PHE THR LYS ALA THR PRO LEU SEQRES 18 A 261 SER SER THR VAL THR LEU SER MET SER ALA ASP VAL PRO SEQRES 19 A 261 LEU VAL VAL GLU TYR LYS ILE ALA ASP MET GLY HIS LEU SEQRES 20 A 261 LYS TYR TYR LEU ALA PRO LYS ILE GLU ASP GLU GLU GLY SEQRES 21 A 261 SER SEQRES 1 B 22 GLY ARG LYS ARG ARG GLN THR SER MET THR ASP PHE PHE SEQRES 2 B 22 HIS SER LYS ARG ARG LEU ILE PHE SER SEQRES 1 C 261 MET PHE GLU ALA ARG LEU VAL GLN GLY SER ILE LEU LYS SEQRES 2 C 261 LYS VAL LEU GLU ALA LEU LYS ASP LEU ILE ASN GLU ALA SEQRES 3 C 261 CYS TRP ASP ILE SER SER SER GLY VAL ASN LEU GLN SER SEQRES 4 C 261 MET ASP SER SER HIS VAL SER LEU VAL GLN LEU THR LEU SEQRES 5 C 261 ARG SER GLU GLY PHE ASP THR TYR ARG CYS ASP ARG ASN SEQRES 6 C 261 LEU ALA MET GLY VAL ASN LEU THR SER MET SER LYS ILE SEQRES 7 C 261 LEU LYS CYS ALA GLY ASN GLU ASP ILE ILE THR LEU ARG SEQRES 8 C 261 ALA GLU ASP ASN ALA ASP THR LEU ALA LEU VAL PHE GLU SEQRES 9 C 261 ALA PRO ASN GLN GLU LYS VAL SER ASP TYR GLU MET LYS SEQRES 10 C 261 LEU MET ASP LEU ASP VAL GLU GLN LEU GLY ILE PRO GLU SEQRES 11 C 261 GLN GLU TYR SER CYS VAL VAL LYS MET PRO SER GLY GLU SEQRES 12 C 261 PHE ALA ARG ILE CYS ARG ASP LEU SER HIS ILE GLY ASP SEQRES 13 C 261 ALA VAL VAL ILE SER CYS ALA LYS ASP GLY VAL LYS PHE SEQRES 14 C 261 SER ALA SER GLY GLU LEU GLY ASN GLY ASN ILE LYS LEU SEQRES 15 C 261 SER GLN THR SER ASN VAL ASP LYS GLU GLU GLU ALA VAL SEQRES 16 C 261 THR ILE GLU MET ASN GLU PRO VAL GLN LEU THR PHE ALA SEQRES 17 C 261 LEU ARG TYR LEU ASN PHE PHE THR LYS ALA THR PRO LEU SEQRES 18 C 261 SER SER THR VAL THR LEU SER MET SER ALA ASP VAL PRO SEQRES 19 C 261 LEU VAL VAL GLU TYR LYS ILE ALA ASP MET GLY HIS LEU SEQRES 20 C 261 LYS TYR TYR LEU ALA PRO LYS ILE GLU ASP GLU GLU GLY SEQRES 21 C 261 SER SEQRES 1 D 22 GLY ARG LYS ARG ARG GLN THR SER MET THR ASP PHE PHE SEQRES 2 D 22 HIS SER LYS ARG ARG LEU ILE PHE SER SEQRES 1 E 261 MET PHE GLU ALA ARG LEU VAL GLN GLY SER ILE LEU LYS SEQRES 2 E 261 LYS VAL LEU GLU ALA LEU LYS ASP LEU ILE ASN GLU ALA SEQRES 3 E 261 CYS TRP ASP ILE SER SER SER GLY VAL ASN LEU GLN SER SEQRES 4 E 261 MET ASP SER SER HIS VAL SER LEU VAL GLN LEU THR LEU SEQRES 5 E 261 ARG SER GLU GLY PHE ASP THR TYR ARG CYS ASP ARG ASN SEQRES 6 E 261 LEU ALA MET GLY VAL ASN LEU THR SER MET SER LYS ILE SEQRES 7 E 261 LEU LYS CYS ALA GLY ASN GLU ASP ILE ILE THR LEU ARG SEQRES 8 E 261 ALA GLU ASP ASN ALA ASP THR LEU ALA LEU VAL PHE GLU SEQRES 9 E 261 ALA PRO ASN GLN GLU LYS VAL SER ASP TYR GLU MET LYS SEQRES 10 E 261 LEU MET ASP LEU ASP VAL GLU GLN LEU GLY ILE PRO GLU SEQRES 11 E 261 GLN GLU TYR SER CYS VAL VAL LYS MET PRO SER GLY GLU SEQRES 12 E 261 PHE ALA ARG ILE CYS ARG ASP LEU SER HIS ILE GLY ASP SEQRES 13 E 261 ALA VAL VAL ILE SER CYS ALA LYS ASP GLY VAL LYS PHE SEQRES 14 E 261 SER ALA SER GLY GLU LEU GLY ASN GLY ASN ILE LYS LEU SEQRES 15 E 261 SER GLN THR SER ASN VAL ASP LYS GLU GLU GLU ALA VAL SEQRES 16 E 261 THR ILE GLU MET ASN GLU PRO VAL GLN LEU THR PHE ALA SEQRES 17 E 261 LEU ARG TYR LEU ASN PHE PHE THR LYS ALA THR PRO LEU SEQRES 18 E 261 SER SER THR VAL THR LEU SER MET SER ALA ASP VAL PRO SEQRES 19 E 261 LEU VAL VAL GLU TYR LYS ILE ALA ASP MET GLY HIS LEU SEQRES 20 E 261 LYS TYR TYR LEU ALA PRO LYS ILE GLU ASP GLU GLU GLY SEQRES 21 E 261 SER SEQRES 1 F 22 GLY ARG LYS ARG ARG GLN THR SER MET THR ASP PHE PHE SEQRES 2 F 22 HIS SER LYS ARG ARG LEU ILE PHE SER FORMUL 7 HOH *1927(H2 O) HELIX 1 1 GLY A 9 ALA A 18 1 10 HELIX 2 2 GLU A 55 PHE A 57 5 3 HELIX 3 3 LEU A 72 LYS A 80 1 9 HELIX 4 4 SER A 141 SER A 152 1 12 HELIX 5 5 LEU A 209 THR A 216 1 8 HELIX 6 6 LYS A 217 SER A 222 5 6 HELIX 7 7 SER B 146 PHE B 150 5 5 HELIX 8 8 GLY C 9 ALA C 18 1 10 HELIX 9 9 GLU C 55 PHE C 57 5 3 HELIX 10 10 LEU C 72 LYS C 80 1 9 HELIX 11 11 SER C 141 SER C 152 1 12 HELIX 12 12 LEU C 209 THR C 216 1 8 HELIX 13 13 LYS C 217 SER C 222 5 6 HELIX 14 14 SER D 146 PHE D 150 5 5 HELIX 15 15 GLY E 9 ALA E 18 1 10 HELIX 16 16 LEU E 72 LYS E 80 1 9 HELIX 17 17 SER E 141 SER E 152 1 12 HELIX 18 18 LEU E 209 THR E 216 1 8 HELIX 19 19 LYS E 217 SER E 222 5 6 HELIX 20 20 SER F 146 PHE F 150 5 5 SHEET 1 A 5 THR A 59 CYS A 62 0 SHEET 2 A 5 PHE A 2 LEU A 6 -1 N GLU A 3 O ARG A 61 SHEET 3 A 5 ILE A 87 ALA A 92 -1 O ILE A 88 N LEU A 6 SHEET 4 A 5 THR A 98 GLU A 104 -1 O ALA A 100 N ARG A 91 SHEET 5 A 5 VAL A 111 LYS A 117 -1 O MET A 116 N LEU A 99 SHEET 1 B 9 LEU A 66 ASN A 71 0 SHEET 2 B 9 GLU A 25 SER A 31 -1 N ILE A 30 O LEU A 66 SHEET 3 B 9 GLY A 34 MET A 40 -1 O GLY A 34 N SER A 31 SHEET 4 B 9 SER A 46 ARG A 53 -1 O LEU A 52 N VAL A 35 SHEET 5 B 9 GLY A 245 LEU A 251 -1 O HIS A 246 N THR A 51 SHEET 6 B 9 LEU A 235 ILE A 241 -1 N TYR A 239 O LEU A 247 SHEET 7 B 9 THR A 224 MET A 229 -1 N THR A 226 O GLU A 238 SHEET 8 B 9 CYS A 135 PRO A 140 -1 N CYS A 135 O MET A 229 SHEET 9 B 9 THR A 196 MET A 199 -1 O GLU A 198 N VAL A 136 SHEET 1 C 2 LEU A 121 GLY A 127 0 SHEET 2 C 2 HIS B 152 ILE B 158 -1 O LYS B 154 N GLN A 125 SHEET 1 D 4 GLY A 176 SER A 183 0 SHEET 2 D 4 GLY A 166 GLY A 173 -1 N VAL A 167 O LEU A 182 SHEET 3 D 4 ALA A 157 CYS A 162 -1 N SER A 161 O LYS A 168 SHEET 4 D 4 VAL A 203 ALA A 208 -1 O VAL A 203 N CYS A 162 SHEET 1 E 2 LYS A 254 ILE A 255 0 SHEET 2 E 2 ARG B 143 GLN B 144 -1 O ARG B 143 N ILE A 255 SHEET 1 F 5 THR C 59 CYS C 62 0 SHEET 2 F 5 PHE C 2 LEU C 6 -1 N GLU C 3 O ARG C 61 SHEET 3 F 5 ILE C 87 ALA C 92 -1 O ILE C 88 N LEU C 6 SHEET 4 F 5 THR C 98 GLU C 104 -1 O ALA C 100 N ARG C 91 SHEET 5 F 5 VAL C 111 LYS C 117 -1 O TYR C 114 N LEU C 101 SHEET 1 G 9 LEU C 66 ASN C 71 0 SHEET 2 G 9 GLU C 25 SER C 31 -1 N ALA C 26 O VAL C 70 SHEET 3 G 9 GLY C 34 MET C 40 -1 O ASN C 36 N ASP C 29 SHEET 4 G 9 SER C 46 ARG C 53 -1 O LEU C 52 N VAL C 35 SHEET 5 G 9 GLY C 245 LEU C 251 -1 O LYS C 248 N GLN C 49 SHEET 6 G 9 LEU C 235 ILE C 241 -1 N VAL C 237 O TYR C 249 SHEET 7 G 9 THR C 224 MET C 229 -1 N SER C 228 O VAL C 236 SHEET 8 G 9 CYS C 135 PRO C 140 -1 N MET C 139 O VAL C 225 SHEET 9 G 9 THR C 196 MET C 199 -1 O GLU C 198 N VAL C 136 SHEET 1 H 2 LEU C 121 GLY C 127 0 SHEET 2 H 2 HIS D 152 ILE D 158 -1 O HIS D 152 N GLY C 127 SHEET 1 I 4 GLY C 176 SER C 183 0 SHEET 2 I 4 GLY C 166 GLY C 173 -1 N VAL C 167 O LEU C 182 SHEET 3 I 4 ALA C 157 ALA C 163 -1 N ALA C 163 O GLY C 166 SHEET 4 I 4 VAL C 203 ALA C 208 -1 O PHE C 207 N VAL C 158 SHEET 1 J 5 THR E 59 CYS E 62 0 SHEET 2 J 5 PHE E 2 LEU E 6 -1 N GLU E 3 O ARG E 61 SHEET 3 J 5 ILE E 87 ALA E 92 -1 O ALA E 92 N PHE E 2 SHEET 4 J 5 THR E 98 GLU E 104 -1 O VAL E 102 N THR E 89 SHEET 5 J 5 VAL E 111 LYS E 117 -1 O MET E 116 N LEU E 99 SHEET 1 K 9 LEU E 66 ASN E 71 0 SHEET 2 K 9 GLU E 25 ILE E 30 -1 N ALA E 26 O VAL E 70 SHEET 3 K 9 GLY E 34 MET E 40 -1 O ASN E 36 N ASP E 29 SHEET 4 K 9 SER E 46 ARG E 53 -1 O LEU E 52 N VAL E 35 SHEET 5 K 9 GLY E 245 LEU E 251 -1 O HIS E 246 N THR E 51 SHEET 6 K 9 LEU E 235 ILE E 241 -1 N VAL E 237 O TYR E 249 SHEET 7 K 9 THR E 224 MET E 229 -1 N SER E 228 O VAL E 236 SHEET 8 K 9 CYS E 135 PRO E 140 -1 N CYS E 135 O MET E 229 SHEET 9 K 9 THR E 196 MET E 199 -1 O GLU E 198 N VAL E 136 SHEET 1 L 2 ASP E 122 LEU E 126 0 SHEET 2 L 2 SER F 153 LEU F 157 -1 O LYS F 154 N GLN E 125 SHEET 1 M 4 GLY E 176 SER E 183 0 SHEET 2 M 4 GLY E 166 GLY E 173 -1 N GLY E 173 O GLY E 176 SHEET 3 M 4 ALA E 157 CYS E 162 -1 N SER E 161 O LYS E 168 SHEET 4 M 4 VAL E 203 ALA E 208 -1 O LEU E 205 N ILE E 160 SSBOND 1 CYS E 135 CYS E 162 1555 1555 2.03 CISPEP 1 ASN A 107 GLN A 108 0 -3.42 CRYST1 142.970 142.970 41.410 90.00 90.00 120.00 P 3 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006994 0.004038 0.000000 0.00000 SCALE2 0.000000 0.008077 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024149 0.00000